Affordably Source Vaccine Experts and Industry Participants for Market Research, Diligence and Projects

Submit an anonymous Project Description -- Start receiving responses within a few hours

Have a need? Explain it here






How Zintro Works

  1. 1. Provide a clear description of your needs and your expectations of an expert, consultant or job candidate and Zintro will match it with the most relevant professionals in our platform.
  2. 2. Within a day or two typically 6 - 12 Experts, who have opted-in, will contact you with a brief explanation of their qualifications and how they can help.
  3. 3. You can communicate back and forth, qualify each other, connect and pay fees to Experts through Zintro.
  4. Zintro is free, anonymous and without obligation.

Loved by Thousands

Loved by thousands logos

Need Help?A phone icon1-877-236-7016

Recent Vaccine Inquiries

Area Icon

Vaccine Adjuvants

We would like to conduct paid expert interviews with experts knowledgeable about the global market size for vaccine adjuvants for the year 2015. Thanks in advance

  1. Profile Picture

    Sunil |Zintro Expert - Formulation Development

    Since I am working for large volume vaccine manufacturers since last many year who had directly hand...

    3.6 Hours Later
  2. Profile Picture

    B |abc

    Dear Inquirer: I am a professional with more than 10 years of experience in Life Science project ma...

    13.6 Hours Later
+4 Other Responses
Area Icon

Animal Health Biologics Cmo

Below are queries for animal/veterinary biologics cmo market 1. Who are the major animal biologic cmo suppliers in europe and north america and what is their annual production capacity? 2. What is the cost structure of cmo (contract manufacturing organization) of animal biologic products such as vaccine/monoclonal antibodies some insights on drug product, drug substance could be useful thanks & regards

  1. Profile Picture

    Shakeel |Director

    Fabgennix and Capralogics are the two major sources we use for animals based biologics development i...

    1 Hour Later
  2. Profile Picture

    Timothy |Director Of Research and Development

    CMOs focused in the veterinary market have been expending in the US and Europe in particular in rece...

    1.9 Hours Later
  3. Profile Picture

    VICTOR |Zintro Expert

    Thanks for the ***** below are my feedbacks based on your quesries 1. Some of the supplie...

    10.2 Hours Later
+13 Other Responses
Area Icon

Hepatitis Vaccines

We are a research firm working on hepatitis b market. We have the following questions: 1. Where does merck manufacture the recombivax vaccine doses globally? Do they use the same facility for being used for vaxelis? 2.. what is the overall capacity of this facility and is there extra capacity being built for the vaxelis launch? 3. What is the reason behind the interrupted supply of recombivax in the u.S. Market? 4. Do the manufacturing facilities have issues with regulatory authorities (warning letters, etc.) preventing product supply? 5.What impact, if any, does a shortage in recombivax supply affect the launch of vaxelis? 6.What will the customer allocations be when recombivax supply resumes to market? Do let us know if you can answer these questions.

  1. Profile Picture

    Barry |Principal, Barry Garfinkle & Associates

    I can answer many of these questions. I would limit some of my answers to not disclose proprietary ...

    1.4 Days Later
  2. Profile Picture

    C.P. |Independent Pharmaceuticals Professional

    Dear Sir/Madam, I am Shastry, from Pharma Synergies, India. I am an 'Independent *****ma B...

    3.2 Days Later
  3. Profile Picture

    Antonio |Director Laboratory Medical Microbiology

    I may discuss on composition and activity of recombiant HBs vaccine from GSK. However, I may not hav...

    3.4 Days Later
+6 Other Responses
Area Icon

Vaccine Research And Development

Consultant (knows science and marketing/commercialization of vaccines)to provide deep insight into the current vaccine market, current regulations and rules governing vaccines in us/global, important considerations in developing and manufacturing vaccines and the opportunity for norovirus vaccine, non-live rotavirus vaccine, and a combination norovirus/rotavirus vaccine

  1. Profile Picture

    Clifford |Founder & President

    I have a strong background in the development and *****oval of vaccines. I would be happy ...

    20 Minutes Later
  2. Profile Picture

    Elizabeth |President

    My interest is in DNA vaccines as I have technology that is relevant to this area....

    3.2 Hours Later
  3. Profile Picture

    Adi |Life Science Consultant / Analyst

    Hi, I am an experienced Life Science Analyst/Consultant, with proven skills in biotech/pharma resea...

    3.5 Hours Later
+6 Other Responses
Area Icon

Pharmaceuticals, Vaccines And Consumer Products Distribution

"pharmaceuticals, vaccines and consumer products-distribution sourcing" geography: europe 1. Sourcing best practice a. What are the sourcing approaches followed by global organizations when dealing with distributors/wholesalers across pharmaceutical, consumer and vaccine business? (centralized/decentralized) 2. Engagement best practice a. What is the best practice followed by companies when engaging for distribution services across pharmaceutical, consumer and vaccine business? I. Is it engaging with a distributor or wholesaler? · global/regional/local distributors? · single or multiple distributors? 3. Feasibility of integrating the distribution model for pharmaceuticals, consumer and vaccine business a. How do companies with multiple business units such as pharmaceutical, consumer and vaccine business manage this category? I. Is there a chance of integrating the distribution of these three business units with single set of distributors? Ii. What are the advantages and disadvantages of following the integration approach?

  1. Profile Picture

    Debasish |HEAD SUPPLY CHAIN

    Please refer my profile...

    6.6 Hours Later
  2. Profile Picture

    Yevgen |Scientific Director

    Hello. I can help. I'm GDP Expert, Director of CRO and ex Marketing Director in Big Pharma....

    6.7 Hours Later
  3. Profile Picture

    Polina |Oversight & Monitoring Lead, Health Care

    I can speak from a procurement perspective. Would you like to schedule a call for next week?...

    7.7 Hours Later
+9 Other Responses
Area Icon

Vaccines

I am currently working on a cost model for vaccines. To develop the cost model we are in need of an expert who can give us the following components. Major cost components: - utility cost - labor cost & overhead cost - fixed cost detailed split of all the cost components need to be described e.G. Bioreactor cost, type of bioreactor, etc. Note: the cost model is to be developed for a 100% disposable facility.

  1. Profile Picture

    Richard |Chief Executive Officer

    I have worked in a number of different ***** have developed cost models for the following...

    7 Hours Later
  2. Profile Picture

    Dr Venkat |Global Consultant

    I have friends who own Vaccine R&D and Manufacturing companies and colleagues with Technical experti...

    7.2 Hours Later
  3. Profile Picture

    Barry |Principal, Barry Garfinkle & Associates

    I have worked in the vaccine area for over 35 years at Merck and Co. Inc. I was responsible for the...

    7.4 Hours Later
+9 Other Responses
Area Icon

Flu Vaccine

My name is claudia and i work in berlin for the company ap. I am looking for key opinion leaders in europe (uk, france and germany) to attend a phone interview about flu vaccines and to speak about these topics: - the outlook for demand for flu vaccines over the coming years. - current flu vaccines in the european market and their relatives strengths and weaknesses. - the outlook for new technologies for flu vaccines in the future.

  1. Profile Picture

    Lokesh |Program Director

    Dear Claudia, I have several years developing vaccine including flu vaccine, both live attenuated ...

    39 Minutes Later
  2. Profile Picture

    Gopalam |Senior Director

    I am interested in this phone consult. I am in vaccines area and worked in the flu vaccines are dir...

    9.9 Hours Later
+3 Other Responses
Area Icon

Vaccine Policy

We are looking to get connected with experts who can help us understand the developing market vaccine industry in india. Some pointers to the project are mentioned below:- 1) who approval process for suppliers; donor selection process for suppliers 2) pentavalent vaccine substitution risk from hexavalent vaccines 3) trends for major vaccines such as pneumococcal vaccines, diphtheria, tetanus 4) pricing trends for pentavalent vaccine 5) new vaccines in pipeline 6) uniqueness of r&d and manufacturing processes - gavi, unicef, paho (internationally) - major indian vaccine companies €“ gsk, sanofi, panacea biotec, serum kindly get in touch with me

  1. Profile Picture

    Marc |Principal

    As a former CEO of Canada's largest pharmacist ***** as a integral member of both provinc...

    1 Day Later
  2. Profile Picture

    Ranajit |Director & Partner

    I am interested in this phone consult opportunity. I have worked with a pioneering vaccine maker for...

    2 Days Later
  3. Profile Picture

    Vikram |Consultant

    Medical Doctor with 10years Experience in various pharma & Clinical research domains : clinical Oper...

    17.3 Days Later
+4 Other Responses
Area Icon

Covid 19 Vaccine Programs

We are interested in speaking with experts who are familiar with the covid 19 vaccine programs. This would be for a 1-hour paid phone consultation. Below are some of the discussion points. Kindly answer with a yes/no or a few brief statements. 1. Would you be able to provide an overview on how big will the study need to be? What happens if we don’t have much disease at the time? 2. Can you speak about how likely is an active challenge study arm? Will surrogate markers be acceptable? 3. Can you share your insights if rna or dna vaccines work? Why do they work? When will we have covid 19 vaccine? **please note that we are only interested in your personal point of view and are not seeking confidential information. ***referrals are highly appreciated

  1. Profile Picture

    Sathibalan |Chief Scientific Officer

    Yes I will be able to discuss the topic as described. I am available at any time....

    53 Minutes Later
  2. Profile Picture

    Margaret |Consultant and Advisor

    I have recently researched and have a deep understanding of *****g applied to vaccine devel...

    1 Hour Later
  3. Profile Picture

    Barry |Principal, Barry Garfinkle & Associates

    I am a PhD virologist with 35 years experience in MRK vaccine development and manufacturing. Former...

    1.2 Hours Later
+39 Other Responses
Area Icon

Chief Medical Officer - Vaccine Development

Chief medical officer. Our client is seeking a chief medical officer to lead the development clinical strategy for its vaccines franchise. This role will be focused on establishing the franchise's development strategy and will work closely with members of the executive team in establishing clinical endpoints, development protocols safety review and regulatory guidelines. The position is further responsible for providing medical guidance during the design, execution, and reporting of clinical studies. More info available upon request. U.S. Residents only, please. Please provide credentials, if interested. If you refer someone who is hired by client for this role, zintro will pay you $2,000. Thanks. --sl

  1. Profile Picture

    Constantin |Zintro Expert

    Thank you very much. I am interested in such position. Note that I am MSc, PhD and not Certified M.D...

    23 Minutes Later
  2. Profile Picture

    Arvind |Assistant Professor

    I am interested, but I am PhD not MD degree holder. Let me know if I am eligible Thanks Arvind Chhab...

    45 Minutes Later
  3. Profile Picture

    Wayne |Principal

    I am a physician trained in immunology with experience in the vaccine and cancer immunotherapy field...

    1.3 Hours Later
+24 Other Responses
Area Icon

Transformative Immunotherapy Vaccines

We are looking for experts in "transformative immunotherapy vaccines" to provide commentary and insights towards a startup that is developing transformative immunotherapy vaccines for infectious diseases and cancer targeting chronic hepatitis b virus (hbv) infection. We are an angel investing platform dedicated to connecting deep-tech startups with angel investors. By deep-tech we mean startups founded on scientific breakthroughs and technological innovations that create lasting impact on mankind. As a participating expert* in this process, your involvement is limited to answering anywhere between 8-12 investor-submitted questions. This takes about 1 hour (+/-) . Once you are vetted, we send those questions via a web form for your responses. If your contribution is published, it will be view-able by potential investors in this startup, giving you an opportunity to make connections, socialize virtually, and gain bragging rights in a vibrant entrepreneurial and angel investing community. ### please respond to this inquiry with your email address. ### *at this point, we cannot guarantee any monetary reimbursement. You do get insights to new upcoming technologies in your field and a tremendous networking opportunity!

  1. Profile Picture

    B |abc

    Dear Client: I am a professional with more than 10 years of experience in biotechnology and life sc...

    1.2 Hours Later
  2. Profile Picture

    Jyotsna |Bio-medical Scientist

    I am a PhD, with 10+ years of research experience in the field of infectious diseases, virology, vir...

    1.7 Hours Later
  3. Profile Picture

    Mohan |Director

    *****arch ***** in-depth understanding of immunology, specifically cancer immu...

    2.5 Hours Later
+24 Other Responses
Area Icon

Vaccine Raw Materials

We are a large multinational firm looking to better understand the following as it relates to cgmp (current good manufacturing practices) vaccine manufacturing raw material costs: 1. What would be typical raw material costs per dose of a liquid vaccine? By what factor would it be higher for lyophilized bulk? 2. What would be the major cost contributors to raw materials? 3. Are these the same for single antigen/ multi-antigen vaccines per unit? If not, what factor would apply to the multi-antigen vaccine? Would a factor of 4x be appropriate for a pentavalent vaccine compared to a single-valent vaccine? 4. Do the cost of these differ if manufactured in us/ europe or india? We are considering a factor of 2 for procurement abroad, would this be a fair assumption? Why would there be such a variance? 5. Would costs vary if the material is sourced from different countries? What country suppliers supply material at lower rates? Comparatively at what multiple is the cost for the suppliers offering highest quality material? 6. What components of raw materials are commodities and do not differ in cost across the world? 7. Would the raw material costs vary if procured in small quantities versus large quantities? What multiple can we consider for small volume players compared to large volume players? 8. Are there any losses associated with blending multiple antigens? Would 0.05 cents per dose be an appropriate figure? 9. Compared to the pentavalent vaccine would rota, ipv, hpv, pneumococcal vaccines have higher rm costs? What could be the reasons for such a hike in cost and by how much would the cost be higher? 10. Is there an additional rm cost due to loss of antigen for sensitive antigens like ipv? 11. What factor should we consider to account for the learning curve? What would be the initial rm costs to say 3 – 5 years down the line? Is it half or 10%? What drives this? Is it because of yield losses? Any there any other factors. 12. In summary, what be the average raw material cost differences between those for simple versus complex vaccines? *please describe your relevant expertise and attach your cv. Thank you.

  1. Profile Picture

    John E. |Principal; Member-Manager

    This is not in my area of expertise. -- John E. Lincoln...

    43 Minutes Later
  2. Profile Picture

    Peter |Managing Partner

    I'm happy to help. To start I'm a 33 year pharma / biotech manufacturing and supply chain professio...

    6.7 Hours Later
  3. Profile Picture

    Ranjit |Sr Marketing Manager Exports

    Yes I can help you I have done similar consultancy with different clients across the globe. I have...

    17.8 Hours Later
+13 Other Responses
See More Inquiries

Top Vaccine Experts

See More Experts
Share
LinkedInTwitterFacebookGoogle+